New Delhi, May 17, 2020: A number of fiscal and regulatory stimulus measures have been announced by the Government. The INR 10,000 crore incentive scheme announced by the government for boosting domestic manufacturing of bulk-drugs and medical devices will go a long way in reducing India’s dependence on imports. The ruling government has also realised the role of technology in transforming the sector. Measures such as rolling out of guidelines for tele-medicine and doorstep delivery will have a long-term impact. Implementation of the National Digital Health Blueprint is a strategic step towards ensuring digitisation of health records and better management of public healthcare outcomes.” Sidharrth Shankar, Partner, at J Sagar Associates
All these reforms and initiatives announced by the government are welcome steps for not only public but also for healthcare sector. However the government also needs to be careful and conscious that the reform reaches to the intended recipient and does not drift away during the process of distribution. Secondly, the government should also take immediate steps to ensure that there is no red tapism and the make in India policy is implemented so that the healthcare manufacturing sector seize more investment from entrepreneurs who are not already investing in the sector.” Dheeraj Nair, Partner, J Sagar Associates
Corporate Comm India (CCI Newswire)
